GB0405406D0 - Anti-vaginitis compositions - Google Patents

Anti-vaginitis compositions

Info

Publication number
GB0405406D0
GB0405406D0 GBGB0405406.0A GB0405406A GB0405406D0 GB 0405406 D0 GB0405406 D0 GB 0405406D0 GB 0405406 A GB0405406 A GB 0405406A GB 0405406 D0 GB0405406 D0 GB 0405406D0
Authority
GB
United Kingdom
Prior art keywords
vaginitis
compositions
vaginitis compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0405406.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EDKO PAZARLAMA TANITIM Ltd STI
Original Assignee
EDKO PAZARLAMA TANITIM Ltd STI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EDKO PAZARLAMA TANITIM Ltd STI filed Critical EDKO PAZARLAMA TANITIM Ltd STI
Priority to GBGB0405406.0A priority Critical patent/GB0405406D0/en
Publication of GB0405406D0 publication Critical patent/GB0405406D0/en
Priority to CNA2004800430095A priority patent/CN1960763A/en
Priority to TR2006/06411T priority patent/TR200606411T1/en
Priority to EA200601647A priority patent/EA011952B1/en
Priority to PCT/GB2004/003972 priority patent/WO2005087270A1/en
Priority to BRPI0418623-0A priority patent/BRPI0418623A/en
Priority to PL380815A priority patent/PL380815A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB0405406.0A 2004-03-10 2004-03-10 Anti-vaginitis compositions Ceased GB0405406D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0405406.0A GB0405406D0 (en) 2004-03-10 2004-03-10 Anti-vaginitis compositions
CNA2004800430095A CN1960763A (en) 2004-03-10 2004-09-17 Anti-vaginitis compositions
TR2006/06411T TR200606411T1 (en) 2004-03-10 2004-09-17 Compositions containing a triazole against vaginitis.
EA200601647A EA011952B1 (en) 2004-03-10 2004-09-17 Anti-vaginitis compositions comprising a triazole
PCT/GB2004/003972 WO2005087270A1 (en) 2004-03-10 2004-09-17 Anti-vaginitis compositions comprising a triazole
BRPI0418623-0A BRPI0418623A (en) 2004-03-10 2004-09-17 pharmaceutical composition and packaging
PL380815A PL380815A1 (en) 2004-03-10 2004-09-17 Vaginal anti-inflammation compositions wiith triazol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0405406.0A GB0405406D0 (en) 2004-03-10 2004-03-10 Anti-vaginitis compositions

Publications (1)

Publication Number Publication Date
GB0405406D0 true GB0405406D0 (en) 2004-04-21

Family

ID=32117416

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0405406.0A Ceased GB0405406D0 (en) 2004-03-10 2004-03-10 Anti-vaginitis compositions

Country Status (7)

Country Link
CN (1) CN1960763A (en)
BR (1) BRPI0418623A (en)
EA (1) EA011952B1 (en)
GB (1) GB0405406D0 (en)
PL (1) PL380815A1 (en)
TR (1) TR200606411T1 (en)
WO (1) WO2005087270A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1667619A4 (en) 2003-09-19 2007-10-10 Drugtech Corp Pharmaceutical delivery system
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
CA2617106A1 (en) * 2005-08-12 2007-02-22 Drugtech Corporation Estrogen compositions and therapeutic methods of use thereof
JP2009522362A (en) * 2006-01-05 2009-06-11 ドラッグテック コーポレイション Drug delivery system
AU2006332518A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
US9211286B2 (en) * 2006-09-12 2015-12-15 Curatek Pharmaceuticals Holding, Inc. Terconazole composition and method
US10758630B2 (en) 2010-08-13 2020-09-01 The Johns Hopkins University Topical compositions and methods of detection and treatment
CN102091097B (en) * 2011-01-28 2013-04-03 武汉耦合医学科技有限责任公司 Washing-free puerpera perineum medical-care gel and preparation method thereof
IT1403661B1 (en) 2011-01-28 2013-10-31 Probiotical Spa EFFERVESCENT COMPOSITION IN THE SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR THE TREATMENT OF VAGINAL INFECTIONS.
ITMI20110792A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF BACTERIA BELONGING TO THE BIFIDOBACTERIUM TYPE FOR USE IN THE TREATMENT OF HYPERCOLESTEROLEMIA.
ITMI20110791A1 (en) 2011-05-09 2012-11-10 Probiotical Spa BACTERIA OF BACTERIA ABLE TO METABOLIZE THE OXALATES.
ITMI20111718A1 (en) 2011-09-23 2013-03-24 Probiotical Spa A WATERPROOF MOISTURE AND OXYGEN MATERIAL FOR PACKAGING DIETARY, COSMETIC AND MEDICINAL PRODUCTS.
WO2014027006A1 (en) 2012-08-13 2014-02-20 Edko Pazarlama Tanitim Ticaret Limited Sirketi Bioadhesive formulations for use in drug delivery
WO2014026707A1 (en) 2012-08-13 2014-02-20 Edko Pazarlama Tanitim Ticaret Limited Sirketi Anti-vaginitis compositions with improved release and adherence
ITMI20130793A1 (en) 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF THE RECURRENT CYCLES.
EP3013368A1 (en) * 2013-06-25 2016-05-04 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
WO2017058175A1 (en) 2015-09-29 2017-04-06 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
BR112022015112A2 (en) * 2020-01-31 2022-09-27 Exeltis Ilac Sanayii Ve Ticaret Anonim Sirketi SUITABLE PHARMACEUTICAL COMPOSITION FOR VAGINAL RELEASE AND USE THEREOF
US11529346B2 (en) * 2020-06-18 2022-12-20 National Medical Supply, LLC Vaginal gel
CN111759840B (en) * 2020-07-20 2021-05-11 温州市人民医院 Pharmaceutical composition for preventing and treating myocardial ischemia and preparation method and application thereof
CN112190541A (en) * 2020-09-27 2021-01-08 安婕妤化妆品科技股份有限公司 Privacy care gel product
CN112245657B (en) * 2020-10-19 2022-07-01 合肥中科智远生物科技有限公司 Low-heat-release antibacterial bone cement and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
JPH09507073A (en) * 1993-12-23 1997-07-15 ザ、プロクター、エンド、ギャンブル、カンパニー Antibacterial wipe composition
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
US20030073646A1 (en) * 1997-01-22 2003-04-17 Marton Milankovits Pharmaceutical compositions primarily for the treatment of genitourinary infections
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
FR2777783A1 (en) * 1998-04-24 1999-10-29 Innothera Lab Sa Pharmaceutical composition for treatment of infectious vulvovaginitis and vaginosis

Also Published As

Publication number Publication date
EA200601647A1 (en) 2007-02-27
BRPI0418623A (en) 2007-05-29
CN1960763A (en) 2007-05-09
PL380815A1 (en) 2007-03-19
TR200606411T1 (en) 2007-01-22
EA011952B1 (en) 2009-06-30
WO2005087270A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
EP1718714A4 (en) Tracer-containing compositions
AP2008004547A0 (en) Petsticidal compositions
ZA200904425B (en) Nemathical compositions
EP1877042A4 (en) Bioenhanced compositions
GB0409375D0 (en) Phytoactive composition
EP1726304A4 (en) Solifenacin-containing composition
GB0501365D0 (en) Compositions
GB0405406D0 (en) Anti-vaginitis compositions
GB0425795D0 (en) Composition
GB0416861D0 (en) Composition
GB0410038D0 (en) Composition
GB0414803D0 (en) Composition
ZA200704974B (en) Composition
GB0415981D0 (en) Composition
GB0417357D0 (en) Composition
ZA200701197B (en) Compositions
GB0410140D0 (en) Compositions
GB0501364D0 (en) Compositions
GB0420627D0 (en) Monoglyceride-containing compositions
GB0425445D0 (en) Novel compositions
GB0417388D0 (en) Composition
GB2418924B (en) Weathered-effect composition
GB0409598D0 (en) Composition
GB0407814D0 (en) Compositions
GB0417860D0 (en) Compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)